Assembly Biosciences Files 8-K

Ticker: ASMB · Form: 8-K · Filed: Jun 25, 2025 · CIK: 1426800

Assembly Biosciences, INC. 8-K Filing Summary
FieldDetail
CompanyAssembly Biosciences, INC. (ASMB)
Form Type8-K
Filed DateJun 25, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: regulatory-filing, financials

Related Tickers: ASMB

TL;DR

ASMB filed an 8-K, likely routine updates on financials/events.

AI Summary

Assembly Biosciences, Inc. filed an 8-K on June 25, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not detail specific transactions or events but serves as a notification of these categories being addressed. The company, formerly Ventrus Biosciences Inc., is incorporated in Delaware and headquartered in South San Francisco, California.

Why It Matters

This 8-K filing indicates that Assembly Biosciences is making required disclosures regarding other events and financial statements, which is a standard regulatory step for public companies.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report and does not contain information about significant new risks or material adverse events.

Key Numbers

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by Assembly Biosciences, Inc. in this 8-K filing?

The filing does not specify the nature of the 'Other Events' beyond listing it as an item information category.

When was Assembly Biosciences, Inc. formerly known as Ventrus Biosciences Inc.?

The date of the name change from Ventrus Biosciences Inc. to Assembly Biosciences, Inc. was February 11, 2008.

What is the primary business of Assembly Biosciences, Inc. according to its SIC code?

Assembly Biosciences, Inc. is classified under Pharmaceutical Preparations (SIC code 2834).

Where are Assembly Biosciences, Inc.'s principal executive offices located?

The principal executive offices are located at Two Tower Place, 7th Floor, South San Francisco, California 94080.

What is the fiscal year end for Assembly Biosciences, Inc.?

The fiscal year end for Assembly Biosciences, Inc. is December 31 (1231).

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 25, 2025 regarding ASSEMBLY BIOSCIENCES, INC. (ASMB).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing